Press Releases

Page Category: 

BOTHELL, WA - March 8, 2006 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced that Mike Schuh, CFO and Anne Bugge, Vice President, Corporate Affairs, will present at the Washington Biotechnology and Biomedical Association (WBBA) 2006 Invest Northwest CEO and Investor Forum on Tuesday, March 21 at 11:15 am PT. The conference is being held at the Bell Harbor Conference Center in Seattle. The presentation will include a review of the company's business strategy and historical financial results. An audio webcast can be accessed via the "Investors" Section of Sonosite's website at www.sonosite.com . The webcast will be available beginning March 21, 2006 and will remain posted for 30 days.

About Sonosite Sonosite, Inc. ( www.sonosite.com ) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 25,000 systems. The company, headquartered near Seattle, Washington, is represented by eight subsidiaries and a global distribution network in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs approximately 500 people worldwide.

New Federal Law on Medicare Reimbursement for AAA Screening Attracts Wide Support BOTHELL, WA - February 15, 2006 - Sonosite, Inc. (Nasdaq:SONO), commented today on the new federal law on Medicare reimbursement for a screening test to detect Abdominal Aortic Aneurysms (AAA) as part of the "Welcome To Medicare Physical Exam." The recent passage of the Screening for Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) Act, which will become effective in 2007, is considered a momentous development within the cardiovascular community. Sonosite, the market leader in hand-carried ultrasound systems, has actively supported passage of this legislation.

"The SAAAVE Act means that thousands of American lives will be saved from this potentially fatal disease," said Kevin M. Goodwin, Sonosite President and CEO. "The SAAAVE Act is among a growing number of examples of the value that hand-carried ultrasound can play in screening for the early detection and management of cardiovascular disease....

Pre-tax income increases 114% for full year; Q4 EPS of $0.32 MicroMaxx system rises to 40% of worldwide revenue in fourth quarter BOTHELL, WA - February 15, 2006 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced record operating results for the fourth quarter and full year ended December 31, 2005. Worldwide revenue in the fourth quarter of 2005 grew 22% to $45.2 million compared with $37.1 million in the fourth quarter of 2004. For the full year of 2005, the company's total revenue grew 27% to $147.5 million compared with $115.8 million for the prior year.

Changes in the foreign currency rates decreased the revenue growth rate by approximately 3% in the fourth quarter and 1% for the full year. In the fourth quarter of 2005, pre-tax income rose 96% to $6.9 million compared with $3.5 million in the fourth quarter of 2004. The company reported net income for the fourth quarter of 2005 of $5.3 million, or $0.32 per diluted share. This compares with fourth quarter 2004 adjusted net income of $2.2 million, or $0.14 per diluted share. This comparison excludes a one-time, non-cash tax benefit in 2004 attributable to the reversal of the $20.8 million valuation allowance for US deferred taxes.

Medical technology executive brings 25 years of experience in Asian markets

BOTHELL, WA - February 9, 2006 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, announced today that it has appointed Peter S.R. Hsu, managing director of Northeast Asia with responsibility for sales and service operations in China/Hong Kong, Japan, Taiwan and South Korea.

Mr. Hsu, a Taiwanese national, has worked in the medical technology field since 1981, primarily based out of China, Taiwan and Hong Kong. Most recently he was senior director of strategic market development for Philips Medical Systems Cardiac and Monitoring Systems in Andover, Mass. From 2001 to 2004, Mr. Hsu served as senior director for Philips Ultrasound Asia Pacific in Hong Kong.

"Peter's broad experience in Asia's primary medical markets is a tremendous asset for Sonosite and our future growth plans," said Graham Cox, Vice President, International. "His sales and market development expertise, in combination with a strong technical background, will accelerate our penetration into these markets."

"In this new role, Peter will be responsible for all business activities in Northeast Asia with a particular focus on building Sonosite's China business," Mr. Cox said. "Based in Shanghai, he will provide important strategic support to our existing China organization and facilitate management of other key markets in surrounding countries."

Former senior partner at Deloitte and Touche brings 33 years of corporate financial expertise BOTHELL, WA - February 7, 2006 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, today announced the appointment of Paul V. Haack, 55, to its Board of Directors and the Board's Audit Committee. Mr. Haack recently retired from Deloitte and Touche as a senior partner, after practicing as a CPA with the firm since 1972. During that time, he held positions of increasing responsibility, most recently as the lead partner on the United Airlines and Boeing accounts in Deloitte's Chicago office.

He also served as lead partner for Boeing during his 28 years in Deloitte's Seattle office. During his career, he was the lead technical partner in Deloitte's Northwest and Milwaukee Practices. "Paul brings a wealth of public company accounting experience to our Board," said Kevin M. Goodwin, Sonosite President and CEO.

Conference Call Accessible Via Live Webcast BOTHELL, WA - February 1, 2006 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, today announced that the Company will report its fourth quarter and 2005 year-end results on Wednesday, February 15, 2006 at the close of market. A conference call will be held at 1:30 pm PT / 4:30 pm ET where management will discuss fourth quarter and year-end performance, outlook for 2006 and current corporate developments.

The call will be broadcast live and can be accessed via the "Investors" Section of Sonosite's website at www.sonosite.com . A replay of the audio webcast will be available beginning February 15, 2006, 4:30 pm (PT) until March 1, 2006, at 9:59 pm (PT) by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code, 2555824, is required to access the replay. The call will also be archived on Sonosite's website at http://ir.sonosite.com .

About Sonosite

Live Webcast Available BOTHELL, WA - January 5, 2006 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, today announced that it will present at the 24th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco on Wednesday, January 11, 2006 at 4:30 pm (PT). A link to the audio-only webcast will be available at http://ir.sonosite.com , beginning Wednesday, January 11, 2006 at 4:30 pm (PT) and ending April 11, 2006.

About Sonosite Sonosite, Inc. ( www.sonosite.com ) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 25,000 systems. The company, headquartered near Seattle, is represented by eight subsidiaries and a global distribution network in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs approximately 470 people worldwide.

BOTHELL, WA - December 20, 2005 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, said today that an independently conducted, random survey of MicroMaxx system customers showed that nearly all customers (97%) surveyed are highly satisfied overall with their MicroMaxx system and would recommend the system to their colleagues. Image quality, ease of use and system durability were key reasons for the high satisfaction rating, with 72% saying that the image quality of the MicroMaxx system is better than other ultrasound products they have used.

Winners Will Be Honored at the Red Herring Fall 2005 Conference SAN FRANCISCO, CA--(MARKET WIRE)--Dec 12, 2005 -- Red Herring announced today its first Red Herring Small Cap 100 list. The editors of the Red Herring evaluated over 2,500 publicly traded technology companies with market capitalizations of between US$300 million and US$1 billion from North America, Europe and the Asia-Pacific region. "Small-cap technology companies are what most tech startups become after they go public," said Joel Dreyfuss, Editor-in-Chief of Red Herring.

"Red Herring's first list of small-cap companies allows us to track the evolution of these companies. We find that small-cap tech companies continue to be innovative even as they fulfill the demands of a competitive public market." The Red Herring Small Cap 100 is based on more than simply financial performance and growth. These public companies possess innovative technology and smart business models that can take them to the next level of competition. Red Herring's global perspective, provocative outlook on the technology landscape and Red Herring Innovation Index will make this list and conference unique and invaluable to technology and financial executives.

BOTHELL, WA - December 8, 2005 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, today said it has signed an agreement with Medtronic Navigation as a non-exclusive distributor for sales and distribution of its ultrasound systems in conjunction with Medtronic Navigation's SonoNav Intra-operative Imaging System used to guide neurosurgery.

The agreement covers distribution of Sonosite systems in the U.S., Canada and thirteen countries in Europe and the Middle East. Ultrasound offers neurosurgeons the benefit of real-time visualization to complement traditional cranial stereotactic systems, which utilize preoperative computed tomography (CT) or magnetic resonance imaging (MRI) data sets to guide surgery. By coupling Sonosite systems to provide real-time intra-operative ultrasound images in correlation with the pre-operative CT or MRI images, the surgeon is able to better monitor and compensate for the movement of the brain caused by tissue removal, edema, etc. as surgery progresses.